Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleonora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti, Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches, «BIOMOLECULES», 2021, 11, Article number: 306, pp. 1 - 28 [articolo]Open Access
Albertini C.; Naldi M.; Petralla S.; Strocchi S.; Grifoni D.; Monti B.; Bartolini M.; Bolognesi M.L., From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease, «MOLECULES», 2021, 26, Article number: 1112, pp. 1 - 22 [articolo]Open Access
Ruolo editoriale nella rivista «Guest editor della special Issue "Microglia in neurodegeneration" nella sezione "Molecular Biology" della rivista Biomolecules»
He, F.; Chou, C. J.; Scheiner, M.; Poeta, E.; Yuan Chen, N.; Gunesch, S.; Hoffmann, M.; Sotriffer, C.; Monti, B.; Maurice, T.; Decker, M., Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model, «JOURNAL OF MEDICINAL CHEMISTRY», 2021, 64, pp. 3794 - 3812 [articolo]Open Access
Gorecki L.; Uliassi E.; Bartolini M.; Janockova J.; Hrabinova M.; Hepnarova V.; Prchal L.; Muckova L.; Pejchal J.; Karasova J.Z.; Mezeiova E.; Benkova M.; Kobrlova T.; Soukup O.; Petralla S.; Monti B.; Korabecny J.; Bolognesi M.L., Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease, «ACS CHEMICAL NEUROSCIENCE», 2021, 12, pp. 1698 - 1715 [articolo]Open Access
Monti B., p57kip2 nuclear export as a marker of oligodendrocytes differentiation: Towards an innovative phenotyping screening for the identification of myelin repair drugs, «EBIOMEDICINE», 2021, 66, Article number: 103298, pp. 1 - 2 [articolo]Open Access
Scheiner M.; Hoffmann M.; He F.; Poeta E.; Chatonnet A.; Monti B.; Maurice T.; Decker M., Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model, «JOURNAL OF MEDICINAL CHEMISTRY», 2021, 64, pp. 9302 - 9320 [articolo]
Rossi M.; Petralla S.; Protti M.; Baiula M.; Kobrlova T.; Soukup O.; Spampinato S.M.; Mercolini L.; Monti B.; Bolognesi M.L., α-linolenic acid-valproic acid conjugates: Toward single-molecule polypharmacology for multiple sclerosis, «ACS MEDICINAL CHEMISTRY LETTERS», 2020, 11, pp. 2406-2413 - 2413 [articolo]Open Access
Marques C.S.; Lopez O.; Bagetta D.; Carreiro E.P.; Petralla S.; Bartolini M.; Hoffmann M.; Alcaro S.; Monti B.; Bolognesi M.L.; Decker M.; Fernandez-Bolanos J.G.; Burke A.J., N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study, «BIOORGANIC CHEMISTRY», 2020, 98, Article number: 103753, pp. 103753 - 103765 [articolo]
Uliassi, Elisa; Pena-Altamira, Luis Emiliano; Morales, Aixa V.; Massenzio, Francesca; Petralla, Sabrina; Rossi, Michele; Roberti, Marinella; Martinez Gonzalez, Loreto; Martinez, Ana; Monti, Barbara; Bolognesi, Maria Laura*, A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential, «ACS CHEMICAL NEUROSCIENCE», 2019, 10, pp. 279 - 294 [articolo]
De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martini C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A., Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507), «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 1357 - 1357 [articolo]
Petralla S.; Pena-Altamira L.E.; Poeta E.; Massenzio F.; Virgili M.; Barile S.N.; Sbano L.; Profilo E.; Corricelli M.; Danese A.; Giorgi C.; Ostan R.; Capri M.; Pinton P.; Palmieri F.; Lasorsa F.M.; Monti B., Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2019, 20, pp. 4486 - 4514 [articolo]Open Access
Montanari S.; Mahmoud A.M.; Pruccoli L.; Rabbito A.; Naldi M.; Petralla S.; Moraleda I.; Bartolini M.; Monti B.; Iriepa I.; Belluti F.; Gobbi S.; Di Marzo V.; Bisi A.; Tarozzi A.; Ligresti A.; Rampa A., Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment, «EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY», 2019, 178, pp. 243 - 258 [articolo]Open Access
De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A., Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease., «ACS MEDICINAL CHEMISTRY LETTERS», 2019, 10, pp. 469 - 474 [articolo]Open Access
Scheiner M.; Dolles D.; Gunesch S.; Hoffmann M.; Nabissi M.; Marinelli O.; Naldi M.; Bartolini M.; Petralla S.; Poeta E.; Monti B.; Falkeis C.; Vieth M.; Hubner H.; Gmeiner P.; Maitra R.; Maurice T.; Decker M., Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo, «JOURNAL OF MEDICINAL CHEMISTRY», 2019, 62, pp. 9078 - 9102 [articolo]Open Access
